Previous studies reported that SLC2A1 expression was up-regulated in non-small cell lung cancer [27], colon cancer [28], and gastric cancer [20], and mediated the glucose transport in cancer cells. This evidence concerns the gene SLC2A1 and malignant colon neoplasm.